MENU
GANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gain Therapeutics (GANX) Ownership - Who owns Gain Therapeutics?

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology... Show more

Profile

Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
21
Web
https://www.gaintherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
79.12M
P/E Ratio
N/A
Total Cash
16.54M
Projected Growth
N/A
Total Debt
672.3K
Revenue
N/A
Risk (Beta)
-0.46
Dividend Yield
N/A
Total Cash/Share
0.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GANX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
21
Web
https://www.gaintherapeutics.com